Related Experiment Video
Updated: Apr 21, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Cadmium exposure and age-related macular degeneration
Myung Hun Kim1,2, Di Zhao3, Juhee Cho3,4,5
1Saevit Eye Hospital, Goyang, Gyeonggi-do, South Korea.
Abstract:
Cadmium (Cd) has been proposed as a risk factor for age-related macular degeneration (AMD), but the association between Cd exposure and AMD risk in large population studies is unknown. This study evaluated the association of Cd exposure with AMD in a large representative sample of Korean men and women. This was a cross-sectional study of 3865 Korean adults ≥ 40 years of age who participated in the Korean National Health and Nutrition Examination Survey (KNHANES) during 2008-2011. Cd concentrations in whole blood were measured by graphite-furnace atomic absorption spectrometry. The presence of AMD was determined in digital non-mydriatic fundus photographs. Cd levels were higher in participants with AMD compared with those without AMD (1.3 vs 1.1 μg/l, respectively, P<0.001). In fully adjusted models, the odds ratio for AMD comparing the highest with the lowest Cd quartiles was 1.92 (95% CI=1.08-3.39; P for trend 0.029). In restricted cubic spline models, the association between Cd and AMD was approximately linear, with no evidence of threshold effects. Blood Cd concentrations were independently associated with the prevalence of AMD. If the association is proven causal, population-based preventive strategies to decrease Cd exposure could reduce the population burden of AMD.
More Related Videos
Related Concept Videos
Photoreceptors and Visual Pathways
Pharmacodynamics in Geriatric Patients: Effects of Age
Coronary Artery Disease I: Introduction
Diabetic Retinopathy
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

